SAMSN1 and Miyoshi myopathy: The fact that Samsn1−/− KaLwRij mice only develop MM with late onset and incomplete penetrance (~1 in 200 mice over two years old)39, 40 suggests that the loss of Samsn1 co‐operates with other genetic lesions to promote disease progression in these mice, and also potentially in patients.